← Back to Search

Augmented Reality (AR) for Learning Difficulties

N/A
Waitlist Available
Led By Thomas J Caruso, MD,PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after simulation
Awards & highlights

Study Summary

This trial evaluates anesthesiology residents' non-technical skills using a remote, international medical simulation based on AHA guidelines.

Who is the study for?
This trial is for anesthesiology residents over the age of 18 who are interested in using Augmented Reality (AR) to improve their non-technical skills during medical crises. It's not suitable for those with nausea, a history of seizures or severe motion sickness, or those who wear corrective glasses as they're incompatible with AR equipment.Check my eligibility
What is being tested?
The study tests how well anesthesiology residents can use AR technology to handle Pediatric Advanced Life Support (PALS) scenarios. Experts from the U.S. will remotely guide participants through AR simulations designed based on American Heart Association best practices.See study design
What are the potential side effects?
While this study does not involve drugs and thus has no medicinal side effects, participants may experience discomfort related to the use of AR such as eye strain, headaches, or dizziness due to motion sickness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after simulation
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after simulation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Individual performance of non-technical skills assessed by Anaesthetist Non-Technical Skills (ANTS)
Secondary outcome measures
Individual performance of non-technical skills assessed by Behaviorally Anchored Rating Scale (BARS)
System Usability Scale (SUS) Score
The International Organization for Standardization (ISO) Ergonomic scale

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mixed Reality SimulationExperimental Treatment1 Intervention
Participants in the experimental arm will be introduced to workplace training modules through an Augmented Reality (AR) headset.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,387 Previous Clinical Trials
17,334,018 Total Patients Enrolled
Thomas J Caruso, MD,PhDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
32 Total Patients Enrolled

Media Library

Mixed Reality Simulation Clinical Trial Eligibility Overview. Trial Name: NCT05940103 — N/A
Learning Difficulties Research Study Groups: Mixed Reality Simulation
Learning Difficulties Clinical Trial 2023: Mixed Reality Simulation Highlights & Side Effects. Trial Name: NCT05940103 — N/A
Mixed Reality Simulation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05940103 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What prerequisites must individuals fulfill to be considered for this research?

"The requirements for entry into this clinical trial are having a cognitive impairment and being between legal adulthood to the elderly stage of life. At present, there is an effort underway to recruit 32 individuals."

Answered by AI

Does this trial accept individuals aged fifty and over?

"This medical study seeks patients aged 18-99. Additionally, there are 8 trials specifically for those below the age of consent and 12 additional studies that target seniors 65 years old or above."

Answered by AI

Are new participants currently being recruited for this experiment?

"Clinicaltrials.gov confirms that this trial, which was initially advertised on September 1 2023 and last edited July 2nd, is no longer recruiting participants. However, 21 different trials are currently open to enrollment at the present moment."

Answered by AI
~21 spots leftby May 2025